154 related articles for article (PubMed ID: 3023422)
1. Lack of suppression of insulin secretion by hyperinsulinemia in a patient with an insulinoma.
Cohen P; Barzilai N; Bar-Ilan R; Yassin K; Karnieli E
J Clin Endocrinol Metab; 1986 Dec; 63(6):1411-3. PubMed ID: 3023422
[TBL] [Abstract][Full Text] [Related]
2. Impaired feedback inhibition of insulin secretion by hyperinsulinemia in patients with insulinoma.
Hiramatsu S; Sako Y; Mimura K; Ono Y; Iwashige K; Taniguchi S; Umeda F; Nawata H
Endocr J; 1995 Feb; 42(1):39-42. PubMed ID: 7599696
[TBL] [Abstract][Full Text] [Related]
3. C-peptide suppression test for insulinoma.
Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
[TBL] [Abstract][Full Text] [Related]
4. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma.
Koivisto VA; Yki-Järvinen H; Hartling SG; Pelkonen R
J Clin Endocrinol Metab; 1986 Nov; 63(5):1117-20. PubMed ID: 3020076
[TBL] [Abstract][Full Text] [Related]
5. Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma.
Kim CH; Park JY; Shong YK; Hong SK; Kim GS; Lee KU
Clin Endocrinol (Oxf); 2000 Jan; 52(1):87-92. PubMed ID: 10651758
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.
Nauck M; Stöckmann F; Creutzfeldt W
Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348
[TBL] [Abstract][Full Text] [Related]
7. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma.
Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W
Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303
[TBL] [Abstract][Full Text] [Related]
8. Study of hypoglycemic patients by the glucose clamp technique using the artificial pancreas.
Pontiroli AE; Secchi A; Dabandi M; Alberetto M; Bosi E; Fantaguzzi S; Pozza G
J Clin Endocrinol Metab; 1983 Dec; 57(6):1297-300. PubMed ID: 6313737
[TBL] [Abstract][Full Text] [Related]
9. Lack of diabetogenic action of calcitonin in subjects affected by insulinoma.
Passariello N; Paolisso G; Iannuzzi F; Pizza G; Marrazzo G; Sgambato S; D'Onofrio F
Diabete Metab; 1989; 15(2):88-92. PubMed ID: 2544469
[TBL] [Abstract][Full Text] [Related]
10. [Discordance between peripheral blood levels of insulin and C-peptide in a case of insulinoma].
Grimaldi A; Brochet E; Bosquet F; Benoliel JJ; Andreassian J; Carayon A
Presse Med; 1984 Sep; 13(31):1901-2. PubMed ID: 6091094
[No Abstract] [Full Text] [Related]
11. Strategy in the diagnosis of insulinoma.
Faber OK; Kehlet H
Scand J Gastroenterol Suppl; 1979; 53():45-8. PubMed ID: 225787
[TBL] [Abstract][Full Text] [Related]
12. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
[TBL] [Abstract][Full Text] [Related]
13. Failure to suppress C-peptide secretion by euglycaemic hyperinsulinaemia: a new diagnostic test for insulinoma?
Yki-Järvinen H; Pelkonen R; Koivisto VA
Clin Endocrinol (Oxf); 1985 Oct; 23(4):461-6. PubMed ID: 2998651
[TBL] [Abstract][Full Text] [Related]
14. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
[TBL] [Abstract][Full Text] [Related]
15. Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma.
Battezzati A; Terruzzi I; Perseghin G; Bianchi E; Di Carlo V; Pozza G; Luzi L
Diabetes; 1995 Jul; 44(7):837-44. PubMed ID: 7789652
[TBL] [Abstract][Full Text] [Related]
16. [Hypoglycemic and hyperinsulinemic clamp technic to determine the secretory behavior of insulinoma].
Hütter R; Irsigler K; Vesely M; Ogris E
Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1146-8. PubMed ID: 2839328
[TBL] [Abstract][Full Text] [Related]
17. [The C-peptide suppression test in normal persons and insulinoma patients: an attempt to evaluate its use in functional diagnosis (author's transl)].
Mandelkow H; Goetz K; Kühnau J
Klin Wochenschr; 1981 Nov; 59(21):1209-15. PubMed ID: 6273644
[No Abstract] [Full Text] [Related]
18. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic.
Roudovitch N; Nauck MA; Schatz H; Pfeiffer AF
Exp Clin Endocrinol Diabetes; 2001; 109(8):397-401. PubMed ID: 11748487
[TBL] [Abstract][Full Text] [Related]
19. Lack of suppression of insulin secretion by exercise in patients with insulinoma.
Järhult J; Ericsson M; Holst J; Ingemansson S
Clin Endocrinol (Oxf); 1981 Oct; 15(4):391-4. PubMed ID: 6274547
[TBL] [Abstract][Full Text] [Related]
20. How reliable is the euglycaemic hyperinsulinemic clamp test for the confirmation of autonomous endogenous hyperinsulinemia?
Mićić D; Popović V; Sumarac M; Kendereski A; Nesović M; Djordjević P; Manojlović D; Mićić J
Exp Clin Endocrinol; 1990 Apr; 95(2):242-50. PubMed ID: 2163878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
